Profilo
Kevin Fitzgerald is the founder of Isogenica Ltd. which was founded in 2000, where he held the title of Chief Executive Officer from 2009 to 2013.
He also held the position of Chief Executive Officer at F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH from 2009 to 2012.
Additionally, he was the Chief Executive Officer & Director at Activiomics Ltd., Chief Operating Officer at Altimmune UK Ltd., and Principal at Actinova Ltd. He holds a doctorate from the University of Cambridge and an MBA from the University of Aston.
Precedenti posizioni note di Kevin Fitzgerald
| Società | Posizione | Fine |
|---|---|---|
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry | Amministratore Delegato | 04/03/2014 |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Presidente | 14/05/2012 |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Direttore operativo | - |
Actinova Ltd.
Actinova Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development services to the biotechonolgy sectors and also develops drugs and vaccines | Corporate Officer/Principal | - |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Fondatore | - |
Formazione di Kevin Fitzgerald
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Health Technology |
Isogenica Ltd.
Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Actinova Ltd.
Actinova Ltd. Pharmaceuticals: MajorHealth Technology Provides research and development services to the biotechonolgy sectors and also develops drugs and vaccines | Health Technology |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry | Commercial Services |
















